Gene Ser219Gly Polymorphism and Venous Thromboembolism: A Meta-Analysis of 9,494 Subjects

Overview

Journal Front Physiol

Date 2017 Jun 13

PMID 28603500

Citations 3

Authors

Yan-Yan Li

Jing-Jing Wu

Xin-Xing Yang

Hong-Yu Geng

Ge Gong

Hyun Jun Kim

Affiliations

Soon will be listed here.

Abstract

Although gene Ser219Gly polymorphism has been associated with venous thromboembolism (VTE) susceptibility, no clear consensus has yet been reached. A meta-analysis of 9,494 subjects from 13 individual studies was conducted to better elucidate the potential relationship between the gene Ser219Gly polymorphism and VTE. Pooled odds ratios (ORs) and their corresponding 95% confidence intervals (CIs) were evaluated by using fixed or random effect models. The current meta-analysis suggested that there was a significant association between gene Ser219Gly polymorphism and VTE under allelic (OR: 1.42, 95% CI: 1.21-1.66, = 1.30 × 10), recessive (OR: 2.02, 95% CI: 1.44-2.85, = 5.35 × 10), homozygous (OR: 2.24, 95% CI: 1.59-3.16, = 3.66 × 10), and additive genetic models (OR: 1.63, 95% CI: 1.30-2.04, = 2.24 × 10). gene Ser219Gly polymorphism was associated with an elevated risk of VTE and the Gly residue carriers of the gene might be predisposed to VTE.

Citing Articles

Endothelial Protein C Receptor and Its Impact on Rheumatic Disease.

OHehir Z, Lynch T, ONeill S, March L, Xue M J Clin Med. 2024; 13(7).

PMID: 38610795 PMC: 11012567. DOI: 10.3390/jcm13072030.

The association between EPCR gene p.Ser219Gly polymorphism and venous thromboembolism risk: a case-control study, meta-analysis, and a reproducibility study.

Pituk D, Miklos T, Schlammadinger A, Razso K, Bereczky Z Front Cardiovasc Med. 2023; 10:1270093.

PMID: 38075960 PMC: 10703307. DOI: 10.3389/fcvm.2023.1270093.

An Exploratory Study Using Next-Generation Sequencing to Identify Prothrombotic Variants in Patients with Cerebral Vein Thrombosis.

Kramer R, Zimmermann R, Strobel J, Achenbach S, Strobel A, Hackstein H Int J Mol Sci. 2023; 24(9).

PMID: 37175682 PMC: 10178986. DOI: 10.3390/ijms24097976.

References

Anastasiou G, Politou M, Rallidis L, Grouzi E, Karakitsos P, Merkouri E . Endothelial Protein C Receptor Gene Variants and Risk of Thrombosis. Clin Appl Thromb Hemost. 2015; 22(2):199-204. DOI: 10.1177/1076029614547261. View

Pecheniuk N, Elias D, Xu X, Griffin J . Failure to validate association of gene polymorphisms in EPCR, PAR-1, FSAP and protein S Tokushima with venous thromboembolism among Californians of European ancestry. Thromb Haemost. 2008; 99(2):453-5. DOI: 10.1160/TH07-10-0607. View

Iverson R, Gomez J . Deep venous thrombosis: prevention and management. Clin Plast Surg. 2013; 40(3):389-98. DOI: 10.1016/j.cps.2013.04.002. View

Liaw P, Neuenschwander P, Smirnov M, Esmon C . Mechanisms by which soluble endothelial cell protein C receptor modulates protein C and activated protein C function. J Biol Chem. 2000; 275(8):5447-52. DOI: 10.1074/jbc.275.8.5447. View

Zoheir N, Eldanasouri N, Abdel-Aal A, Hosny K, Abdel-Ghany W . Endothelial cell protein C receptor gene 6936A/G and 4678G/C polymorphisms as risk factors for deep venous thrombosis. Blood Coagul Fibrinolysis. 2015; 27(3):259-65. DOI: 10.1097/MBC.0000000000000402. View

Castellino F, Ploplis V . The protein C pathway and pathologic processes. J Thromb Haemost. 2009; 7 Suppl 1:140-5. PMC: 3669675. DOI: 10.1111/j.1538-7836.2009.03410.x. View

Cochran W . The effectiveness of adjustment by subclassification in removing bias in observational studies. Biometrics. 1968; 24(2):295-313. View

DerSimonian R, Laird N . Meta-analysis in clinical trials. Control Clin Trials. 1986; 7(3):177-88. DOI: 10.1016/0197-2456(86)90046-2. View

Uitte de Willige S, van Marion V, Rosendaal F, Vos H, de Visser M, Bertina R . Haplotypes of the EPCR gene, plasma sEPCR levels and the risk of deep venous thrombosis. J Thromb Haemost. 2004; 2(8):1305-10. DOI: 10.1046/j.1538-7836.2004.00855.x. View

10.

Qu D, Wang Y, Song Y, Esmon N, Esmon C . The Ser219-->Gly dimorphism of the endothelial protein C receptor contributes to the higher soluble protein levels observed in individuals with the A3 haplotype. J Thromb Haemost. 2006; 4(1):229-35. DOI: 10.1111/j.1538-7836.2005.01676.x. View

11.

Chen X, Tian L, Li M, Jin W, Zhang H, Zheng C . Relationship between endothelial cell protein C receptor gene 6936A/G polymorphisms and deep venous thrombosis. Chin Med J (Engl). 2011; 124(1):72-5. View

12.

Naess I, Christiansen S, Romundstad P, Cannegieter S, Rosendaal F, Hammerstrom J . Incidence and mortality of venous thrombosis: a population-based study. J Thromb Haemost. 2007; 5(4):692-9. DOI: 10.1111/j.1538-7836.2007.02450.x. View

13.

Yamagishi K, Cushman M, Heckbert S, Tsai M, Folsom A . Lack of association of soluble endothelial protein C receptor and PROCR 6936A/G polymorphism with the risk of venous thromboembolism in a prospective study. Br J Haematol. 2009; 145(2):221-6. PMC: 2752823. DOI: 10.1111/j.1365-2141.2009.07612.x. View

14.

Medina P, Navarro S, Estelles A, Vaya A, Woodhams B, Mira Y . Contribution of polymorphisms in the endothelial protein C receptor gene to soluble endothelial protein C receptor and circulating activated protein C levels, and thrombotic risk. Thromb Haemost. 2004; 91(5):905-11. DOI: 10.1160/TH03-10-0657. View

15.

Xu J, Qu D, Esmon N, Esmon C . Metalloproteolytic release of endothelial cell protein C receptor. J Biol Chem. 2000; 275(8):6038-44. DOI: 10.1074/jbc.275.8.6038. View

16.

Karabiyik A, Yilmaz E, Egin Y, Akar N . The Effects of Endothelial Protein C Receptor Gene Polymorphisms on the Plasma sEPCR Level in Venous Thrombosis Patients. Turk J Haematol. 2014; 29(1):55-62. PMC: 3986769. DOI: 10.5152/tjh.2011.40. View

17.

Riewald M, Petrovan R, Donner A, Mueller B, Ruf W . Activation of endothelial cell protease activated receptor 1 by the protein C pathway. Science. 2002; 296(5574):1880-2. DOI: 10.1126/science.1071699. View

18.

Medina P, Navarro S, Estelles A, Vaya A, Bertina R, Espana F . Influence of the 4600A/G and 4678G/C polymorphisms in the endothelial protein C receptor (EPCR) gene on the risk of venous thromboembolism in carriers of factor V Leiden. Thromb Haemost. 2005; 94(2):389-94. DOI: 10.1160/TH05-02-0089. View

19.

Mantel N, Haenszel W . Statistical aspects of the analysis of data from retrospective studies of disease. J Natl Cancer Inst. 1959; 22(4):719-48. View

20.

Navarro S, Medina P, Mira Y, Estelles A, Villa P, Ferrando F . Haplotypes of the EPCR gene, prothrombin levels, and the risk of venous thrombosis in carriers of the prothrombin G20210A mutation. Haematologica. 2008; 93(6):885-91. DOI: 10.3324/haematol.12448. View